221 related articles for article (PubMed ID: 10751358)
1. Cell differentiation and matrix gene expression in mesenchymal chondrosarcomas.
Aigner T; Loos S; Müller S; Sandell LJ; Unni KK; Kirchner T
Am J Pathol; 2000 Apr; 156(4):1327-35. PubMed ID: 10751358
[TBL] [Abstract][Full Text] [Related]
2. [Neoplastic chondroneogenesis as a characteristic of mesenchymal chondrosarcomas].
Schörle CM; Unni KK; Aigner T
Orthopade; 2002 Jun; 31(6):544-50. PubMed ID: 12149925
[TBL] [Abstract][Full Text] [Related]
3. Prognostic relevance of cell biologic and biochemical features in conventional chondrosarcomas.
Aigner T; Müller S; Neureiter D; Illstrup DM; Kirchner T; Björnsson J
Cancer; 2002 Apr; 94(8):2273-81. PubMed ID: 12001127
[TBL] [Abstract][Full Text] [Related]
4. Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases.
Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Rushing EJ
Hum Pathol; 2010 May; 41(5):653-62. PubMed ID: 20138330
[TBL] [Abstract][Full Text] [Related]
5. Cell biology and matrix biochemistry of chondromyxoid fibroma.
Söder S; Inwards C; Müller S; Kirchner T; Aigner T
Am J Clin Pathol; 2001 Aug; 116(2):271-7. PubMed ID: 11488075
[TBL] [Abstract][Full Text] [Related]
6. [Matrix gene expression pattern as indicators of the biology of cartilage-forming tumors].
Aigner T; Unni CC; Bjornsson J; Kirchner T
Verh Dtsch Ges Pathol; 1998; 82():178-83. PubMed ID: 10095430
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic diversity of neoplastic chondrocytes and extracellular matrix gene expression in cartilaginous neoplasms.
Aigner T; Dertinger S; Vornehm SI; Dudhia J; von der Mark K; Kirchner T
Am J Pathol; 1997 Jun; 150(6):2133-41. PubMed ID: 9176404
[TBL] [Abstract][Full Text] [Related]
8. Expression of cartilage extracellular matrix and potential regulatory genes in a new human chondrosarcoma cell line.
Chansky H; Robbins JR; Cha S; Raskind WH; Conrad EU; Sandell LJ
J Orthop Res; 1998 Sep; 16(5):521-30. PubMed ID: 9820274
[TBL] [Abstract][Full Text] [Related]
9. Chondroblastoma is an osteoid-forming, but not cartilage-forming neoplasm.
Aigner T; Loos S; Inwards C; Perris R; Perissinotto D; Unni KK; Kirchner T
J Pathol; 1999 Dec; 189(4):463-9. PubMed ID: 10629544
[TBL] [Abstract][Full Text] [Related]
10. Type II collagen as specific marker for mesenchymal chondrosarcomas compared to other small cell sarcomas of the skeleton.
Müller S; Söder S; Oliveira AM; Inwards CY; Aigner T
Mod Pathol; 2005 Aug; 18(8):1088-94. PubMed ID: 15731776
[TBL] [Abstract][Full Text] [Related]
11. De-differentiated chondrosarcoma is not a 'de-differentiated' chondrosarcoma.
Aigner T; Dertinger S; Neureiter D; Kirchner T
Histopathology; 1998 Jul; 33(1):11-9. PubMed ID: 9726043
[TBL] [Abstract][Full Text] [Related]
12. Type II collagen, but not aggrecan expression, distinguishes clear cell chondrosarcoma and chondroblastoma.
Söder S; Oliveira AM; Inwards CY; Müller S; Aigner T
Pathology; 2006 Feb; 38(1):35-8. PubMed ID: 16484006
[TBL] [Abstract][Full Text] [Related]
13. Matrix biochemistry and cell biology of dedifferentiated chondrosarcomas.
Dornauer K; Söder S; Inwards CY; Bovee JV; Aigner T
Pathol Int; 2010 May; 60(5):365-72. PubMed ID: 20518886
[TBL] [Abstract][Full Text] [Related]
14. ACTH enhances chondrogenesis in multipotential progenitor cells and matrix production in chondrocytes.
Evans JF; Niu QT; Canas JA; Shen CL; Aloia JF; Yeh JK
Bone; 2004 Jul; 35(1):96-107. PubMed ID: 15207745
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal chondrosarcoma: an immunohistochemical study of 10 cases examining prognostic significance of proliferative activity and cellular differentiation.
Nussbeck W; Neureiter D; Söder S; Inwards C; Aigner T
Pathology; 2004 Jun; 36(3):230-3. PubMed ID: 15203726
[TBL] [Abstract][Full Text] [Related]
16. Towards a new understanding and classification of chondrogenic neoplasias of the skeleton--biochemistry and cell biology of chondrosarcoma and its variants.
Aigner T
Virchows Arch; 2002 Sep; 441(3):219-30. PubMed ID: 12242518
[TBL] [Abstract][Full Text] [Related]
17. Matrix gene expression analysis and cellular phenotyping in chordoma reveals focal differentiation pattern of neoplastic cells mimicking nucleus pulposus development.
Gottschalk D; Fehn M; Patt S; Saeger W; Kirchner T; Aigner T
Am J Pathol; 2001 May; 158(5):1571-8. PubMed ID: 11337353
[TBL] [Abstract][Full Text] [Related]
18. Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors.
Wehrli BM; Huang W; De Crombrugghe B; Ayala AG; Czerniak B
Hum Pathol; 2003 Mar; 34(3):263-9. PubMed ID: 12673561
[TBL] [Abstract][Full Text] [Related]
19. BMP2 initiates chondrogenic lineage development of adult human mesenchymal stem cells in high-density culture.
Schmitt B; Ringe J; Häupl T; Notter M; Manz R; Burmester GR; Sittinger M; Kaps C
Differentiation; 2003 Dec; 71(9-10):567-77. PubMed ID: 14686954
[TBL] [Abstract][Full Text] [Related]
20. Type X collagen expression and hypertrophic differentiation in chondrogenic neoplasias.
Aigner T; Frischholz S; Dertinger S; Beier F; Girkontaité I; von der Mark K
Histochem Cell Biol; 1997 Jun; 107(6):435-40. PubMed ID: 9243276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]